-
The Future Of Nano Technology
Categories
- Ai
- Alan Watts
- Anatomy
- Andropause
- Anti-Aging Medicine
- Arthritis
- Artificial General Intelligence
- Artificial Intelligence
- Artificial Super Intelligence
- Ataxia
- Autism
- Biochemistry
- BioEngineering
- Biotechnology
- Bitcoin
- Chemistry
- Cryonics
- Cryptocurrency
- David Sinclair
- Dementia
- Diet Science
- Diseases
- Eczema
- Elon Musk
- Futurism
- Gene Medicine
- Gene Therapy
- Gene therapy
- Genetic Medicine
- Genetic Therapy
- Global News Feed
- Healthy Lifestyle
- Healthy Living
- HGH Physicians
- Hormone Optimization
- Hormone Replacement Therapy
- Hormone Replacement Treatment
- Human Genetic Engineering
- Human Immortality
- Human Longevity
- Human Reproduction
- Hypogonadism
- Hypopituitarism
- Hypothyroidism
- Immortality
- Immortality Medicine
- Inflammation
- Injectable Growth Hormone
- Integrative Medicine
- Life Skills
- Longevity
- Longevity Medicine
- Low T
- Machine Learning
- Mars Colony
- Medical School
- Menopause
- multiple-sclerosis
- Nano Medicine
- Nanomedicine
- Nanotechnology
- Neurology
- Parkinson's disease
- Pharmacogenomics
- Protein Folding
- Psoriasis
- Quantum Computing
- Regenerative Medicine
- Resveratrol
- Sermorelin Physicians
- Singularity
- Spacex
- Stem Cell Therapy
- Stem Cells
- Stemcell Therapy
- Testosterone
- Testosterone Physicians
- Transhuman
- Transhumanism
- Transhumanist
- Uncategorized
- Veganism
- Vegetarianism
- Vitamin Research
- Wellness
-
Recent Posts
- Polyplus Launches Innovative Plasmid for AAV Vector Production, Strengthening Its Position in Biologic and Cell … – BSA bureau
- Orchard Sets $4.25M US Price for Gene Therapy Lenmeldy on Heels of Approval – BioSpace
- Stem Cell Editing Repairs Severe Immunodeficiency – The Scientist
- Opus Genetics Announces Completion of Dosing in First Cohort of Phase 1/2 Trial of Gene Therapy OPGx-LCA5 in … – GlobeNewswire
- New Gene Therapy for Rare MDL to Cost $4.25 Million – Managed Healthcare Executive
Archives
Popular
Search Immortality Topics: |
Category Archives: Stem Cell Therapy
Trounson, Parthenotes and International Stem Cell
The president of the California stem cell agency, Alan Trounson, popped up in a recent article in Scientific American dealing with a method for creating pluripotent stem cells from unfertilized human eggs.
The piece by Julia Galef said that "many investigators remain frustrated" that the method "remains offlimits" for federal funding, a barrier that does not apply to financing from the $3 billion California stem cell agency.
Galef wrote that one California firm, International Stem Cell Corp., of Carlsbad, is using the method to develop products. She said the firm's work involves "a process called parthenogenesis, in which researchers use chemicals to induce the egg to begin developing as if it had been fertilized. The egg—called a parthenote—behaves just like an embryo in the early stages of division. Because it contains no genetic material from a father, however, it cannot develop into a viable fetus."
Trounson was quoted as saying, nonetheless, that "proving that unfertilized eggs will produce stable tissues in humans remains an obstacle." He said other labs need to replicate the work.
International Stem Cell has applied unsuccessfully several times for research funding from the California stem cell agency.
The Scientific American article said,
"International Stem Cell scientists have converted them into liver cells and plan to convert them into neurons for treating Parkinson’s disease, pancreatic cells for diabetes, and other tissues. Meanwhile teams at the Massachusetts-based Bedford Stem Cell Research Foundation are working to improve the efficiency of methods of deriving stem cells from parthenotes."
As researcher interest in parthenotes gains attention, the NIH is being urged to change its negative position. Late last year, Teresa Woodruff, founder and director of the Institute for Women's Health Research at Northwestern University Feinberg School of Medicine, and others called for a lifting of the NIH ban on funding for parthenotes.
California is not constrained by NIH limitations. One of the key reasons, if not the only reason, that voters approved in 2004 the ballot initiative that created the $3 billion stem cell agency was to fund research that the federal government did not. At the time, the focus was on the Bush ban on financing hESC research.
Ken Aldrich, co-chairman of International Stem Cell, circulated the Scientific American article, touting its significance.
We found this posting on the Stem Cell Pioneers web site in which Aldrich said,
“We at International Stem Cell Corporation (ISCO.OB) are finding it increasingly gratifying that mainstream and highly respected publications like Scientific American are now beginning to take notice of the fact that our parthenogenetic stem cells may well turn out to be a viable alternative to the embryonic stem cells that have dominated research and headlines for the last 10 years.
"Like embryonic stem cells, our parthenogenetic stem cells can be converted into almost any kind of cell that might ever be needed for therapy, but can also provide a solution to the two biggest issues that have surrounded embryonic stem cell research: 1) the ethics of destroying a fertilized embryo, which our process never does, and 2) the problem of immune rejection by the patient. We hope you enjoy the attached article."
Source:
http://californiastemcellreport.blogspot.com/feeds/posts/default?alt=rss
Posted in Stem Cell Therapy
Comments Off on Trounson, Parthenotes and International Stem Cell
Anna Deeter Testimonial for Fetal Stem Cell Treatment at EmCell Clinic – Video
Anna Deeter Testimonial for Fetal Stem Cell Treatment at EmCell Clinic
Follow this link:
Anna Deeter Testimonial for Fetal Stem Cell Treatment at EmCell Clinic - Video
Posted in Stem Cell Therapy
Comments Off on Anna Deeter Testimonial for Fetal Stem Cell Treatment at EmCell Clinic – Video
‘Embryonic’ and ‘Adult’ Stem Cell Research Explained by David Kupelian – Video
I learn for the first time the difference between embryonic stem cell therapy and adult stem cell therapy. The media did not explain that Rick Perry's stem cell therapy was "adult" not "embryonic." The media never explains the fact that embryonic stem cell therapy is not working, it's a disaster, and adult stem cell therapy is working. The media has an "irrational infactuation with embryonic stem cell research" because they have to "perfume the stench of abortion." Also, Roe from Roe vs.
The rest is here:
'Embryonic' and 'Adult' Stem Cell Research Explained by David Kupelian - Video
Posted in Stem Cell Therapy
Comments Off on ‘Embryonic’ and ‘Adult’ Stem Cell Research Explained by David Kupelian – Video
Stem Cell Therapy for Multiple Sclerosis and Rheumatoid Arthritis: Scientific Rationale – Video
Neil Riordan PhD presents the scientific rationale for using adipose tissue-derived stem cells and T-regulatory cells to treat MS and rheumatoid arthritis. Dr
View post:
Stem Cell Therapy for Multiple Sclerosis and Rheumatoid Arthritis: Scientific Rationale - Video
Posted in Stem Cell Therapy
Comments Off on Stem Cell Therapy for Multiple Sclerosis and Rheumatoid Arthritis: Scientific Rationale – Video
Stem Cell Treatments for Psoriatic Arthritis: A Case Study – Video
Dr. Neil Riordan presents a case study of a 28 year-old female suffering from psoriatic arthritis who received stem cell therapy at the Stem Cell Institute in Panama City, Panama. The patient describes her progress at the end of this video.
View post:
Stem Cell Treatments for Psoriatic Arthritis: A Case Study - Video
Posted in Stem Cell Therapy
Comments Off on Stem Cell Treatments for Psoriatic Arthritis: A Case Study – Video
Stem Cell Treatment Diabetes – Video
http://www.StemCellTreatment.org This is a testimonial of a diabetes condition patient George.
Read more:
Stem Cell Treatment Diabetes - Video
Posted in Stem Cell Therapy
Comments Off on Stem Cell Treatment Diabetes – Video